C4 Therapeutics Inc (CCCC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2017 | 12-2006 | 12-2005 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 181,727 | 90,549 | N/A | N/A | N/A |
| Marketable Securities | 189,962 | N/A | N/A | N/A | N/A |
| Receivables | 4,484 | 4,623 | N/A | N/A | N/A |
| TOTAL | $381,009 | $96,767 | $N/A | $N/A | $N/A |
| Non-Current Assets | |||||
| PPE Net | 3,323 | 4,463 | N/A | N/A | N/A |
| Other Non-Current Assets | 15,806 | 17,030 | 0 | 0 | 0 |
| TOTAL | $19,129 | $21,493 | $N/A | $N/A | $N/A |
| Total Assets | $400,138 | $118,260 | $N/A | $N/A | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 5,683 | 5,385 | 0 | 0 | 0 |
| Accrued Expenses | 9,524 | 6,671 | N/A | N/A | N/A |
| TOTAL | $43,852 | $33,641 | $N/A | $N/A | $N/A |
| Non-Current Liabilities | |||||
| Long Term Debt | 10,052 | N/A | N/A | N/A | N/A |
| Deferred Revenues | 27,603 | 20,705 | N/A | N/A | N/A |
| Other Non-Current Liabilities | 11,826 | 12,869 | 0 | 0 | 0 |
| TOTAL | $75,495 | $85,587 | $N/A | $N/A | $N/A |
| Total Liabilities | $119,347 | $119,228 | $N/A | $N/A | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 43,119 | N/A | N/A | N/A | N/A |
| Common Shares | 4 | N/A | N/A | N/A | N/A |
| Retained earnings | -183,823 | -117,488 | N/A | N/A | N/A |
| Other shareholders' equity | 13 | 110,995 | 0 | 0 | 0 |
| TOTAL | $280,791 | $-968 | $N/A | $N/A | $N/A |
| Total Liabilities And Equity | $400,138 | $118,260 | $0 | $0 | $0 |